Open AccessA study of the efficacy and tolerability of capecitabine and lobaplatin in advanced HER-2 negative breast cancer patients
Author(s) -
Yuan Yuan,
Lili Zhang,
Zhe Zhang,
Qian Yu,
Yue Teng
Publication year - 2021
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-21-2702
Subject(s) - capecitabine , tolerability , oncology , medicine , breast cancer , adverse effect , human epidermal growth factor receptor 2 , metastatic breast cancer , cancer , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom